EnWave Cuts Co-Manufacturing to Boost Profits by $1M Annually
Event summary
- EnWave to wind down REVworx™ co-manufacturing operations, cutting $1M in annual costs by fiscal 2028.
- $2M in equipment from REVworx™ to be monetized to support future machine sales.
- Company expects net income to improve by at least $1M annually starting fiscal 2028.
- Royalty collections projected to reach $3M annually by end of fiscal 2027.
- 52 licensed royalty partners globally, with several offering commercial-scale REV™ production.
The big picture
EnWave’s move to streamline operations reflects the maturation of its REV™ technology, reducing reliance on internal co-manufacturing. The shift aligns with broader industry trends toward outsourcing production to specialized partners, allowing EnWave to focus on high-value innovation and royalty generation. The company’s 52 global partners provide a scalable ecosystem for commercial adoption, positioning EnWave to capitalize on growing demand for efficient dehydration solutions.
What we're watching
- Royalty Growth
- Whether EnWave can sustain $3M in annualized royalty collections by fiscal 2027.
- Equipment Sales
- The pace at which monetized REVworx™ equipment drives future machine sales.
- Commercial Adoption
- How the shift to external co-manufacturing impacts REV™ technology adoption.
Related topics